We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CS:EURONEXT PARISAXA SA Analysis

Data as of 2026-07-10 - not real-time

$121.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cisco (CS) is trading at $121.31, comfortably above its 20‑day ($117.94), 50‑day ($113.75) and 200‑day ($86.11) simple moving averages, confirming a bullish price trend. The RSI sits at 57, indicating modest momentum, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term weakness as the stock approaches its resistance around $122.89. Volatility is elevated at 41% over the past 30 days and a beta of 1.07 signals sensitivity to market moves. Fundamentally, revenue grew 12% to $60.7 bn with a solid 64% gross margin and 25% operating margin, and forward EPS is projected at $4.78, compressing the forward P/E to 25 versus a trailing 40. The dividend yield of 1.42% is backed by a 55% payout ratio and strong cash flow, though the balance sheet carries $33 bn of debt against $16.6 bn of cash (Debt/Equity ≈ 68%). A discounted cash‑flow model values the stock near $46.8, implying the market price is significantly overvalued. No recent news items are driving the price, so technical levels and valuation gaps dominate the outlook.
Given the mixed technical signals, robust earnings growth, and an unsustainable premium to intrinsic value, we recommend a cautious short‑term hold, a medium‑term buy on earnings momentum, and a long‑term hold to capture dividend income while monitoring valuation compression.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price nearing resistance at $122.89
  • Bearish MACD divergence
  • High short‑term volatility (41%)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 12% revenue growth and expanding margins
  • Forward EPS growth compressing forward P/E to 25
  • Sustainable dividend with 55% payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash flow generation supporting dividend
  • Market leadership in networking and security
  • Valuation gap suggests limited upside

Key Metrics & Analysis

Financial Health

Revenue Growth12.00%
Profit Margin19.68%
P/E Ratio40.3
ROE25.23%
ROA7.34%
Debt/Equity67.54
P/B Ratio9.8
Op. Cash Flow$13.0B
Free Cash Flow$9.3B
Industry P/E34.7

Technical Analysis

TrendBullish
RSI57.7
Support$111.33
Resistance$122.89
MA 20$117.94
MA 50$113.75
MA 200$86.11
MACDBearish
VolumeStable
Fear & Greed Index94.59

Valuation

Fair Value$46.79
Target Price$127.18
Upside/Downside4.84%
GradeOvervalued
TypeGrowth
Dividend Yield1.42%

Risk Assessment

Beta1.07
Volatility41.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.